메뉴 건너뛰기




Volumn 29, Issue 1, 2007, Pages 69-81

Progress report on the Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study: Status at February 2004

(516)  Hosohata, Keiko a   Saito, Shin a   Asayama, Kei a   Ohkubo, Takayoshi a   Kikuya, Masahiro a   Metoki, H c   Obara, Taku a   Kato, Tetsuo a   Hashimoto, Junichiro a   Totsune, Kazuhito a   Miura, Yukio b   Imai, Yutaka a   Arakawa, Kikuo c   Fujishima, Masatoshi c   Fujii, Jun c   Fukiyama, Koushiro c   Hisamichi, Shigeru c   Iimura, Osamu c   Ishii, Masao c   Omae, Teruo c   more..


Author keywords

Blood pressure measurement at home; Hypertension; Internet; Prospective randomized open label blinded endpoint (PROBE); Randomized controlled trial (RCT)

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

EID: 33846016213     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960601096976     Document Type: Article
Times cited : (10)

References (22)
  • 1
    • 0031944128 scopus 로고    scopus 로고
    • Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
    • Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 1998; 21(4):597-603.
    • (1998) Diabetes Care , vol.21 , Issue.4 , pp. 597-603
    • Tatti, P.1    Pahor, M.2    Byington, R.P.3    Di Mauro, P.4    Guarisco, R.5    Strollo, G.6    Strollo, F.7
  • 2
    • 0033589756 scopus 로고    scopus 로고
    • Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 Study
    • Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten B, Wester PO, Hedner T, de Faire U. Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 Study. Lancet 1999;354(9192):1751- 1756.
    • (1999) Lancet , vol.354 , Issue.9192 , pp. 1751-1756
    • Hansson, L.1    Lindholm, L.H.2    Ekbom, T.3    Dahlof, B.4    Lanke, J.5    Schersten, B.6    Wester, P.O.7    Hedner, T.8    de Faire, U.9
  • 3
    • 0032485350 scopus 로고    scopus 로고
    • The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
    • Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 1998;338(10): 645-652.
    • (1998) N Engl J Med , vol.338 , Issue.10 , pp. 645-652
    • Estacio, R.O.1    Jeffers, B.W.2    Hiatt, W.R.3    Biggerstaff, S.L.4    Gifford, N.5    Schrier, R.W.6
  • 5
    • 0037038780 scopus 로고    scopus 로고
    • Optimal trial in myocardial infarction with the angiotensin II antagonist losartan. The OPTIMMAL trial: Losartan or captopril after acute myocardial infarction
    • Fournier A, Andrejak M, Slama M, Godefroy O, Achard JM. Optimal trial in myocardial infarction with the angiotensin II antagonist losartan. The OPTIMMAL trial: losartan or captopril after acute myocardial infarction. Lancet 2002;60(9348):1885-1886.
    • (2002) Lancet , vol.60 , Issue.9348 , pp. 1885-1886
    • Fournier, A.1    Andrejak, M.2    Slama, M.3    Godefroy, O.4    Achard, J.M.5
  • 7
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288(23):2981-2997.
    • (2002) JAMA , vol.288 , Issue.23 , pp. 2981-2997
  • 8
    • 0037434556 scopus 로고    scopus 로고
    • the Second Australian National Blood Pressure Study Group. Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly
    • Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Macdonald GJ, Marley JE, Morgan TO, West MJ, the Second Australian National Blood Pressure Study Group. Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348(7):583-592.
    • (2003) N Engl J Med , vol.348 , Issue.7 , pp. 583-592
    • Wing, L.M.1    Reid, C.M.2    Ryan, P.3    Beilin, L.J.4    Brown, M.A.5    Jennings, G.L.6    Johnston, C.I.7    McNeil, J.J.8    Macdonald, G.J.9    Marley, J.E.10    Morgan, T.O.11    West, M.J.12
  • 9
    • 0037160968 scopus 로고    scopus 로고
    • Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359(9311):995-1003.
    • Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359(9311):995-1003.
  • 10
    • 0037851836 scopus 로고    scopus 로고
    • Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ, the CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289(16):2073-2082.
    • Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ, the CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289(16):2073-2082.
  • 11
    • 85136407194 scopus 로고    scopus 로고
    • Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, the INVEST Investigators. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003;290(21):2805- 2816.
    • Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW, the INVEST Investigators. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003;290(21):2805- 2816.
  • 12
    • 0038031721 scopus 로고    scopus 로고
    • the Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region
    • Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S, the Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003;21(4):707-716.
    • (2003) J Hypertens , vol.21 , Issue.4 , pp. 707-716
    • Lawes, C.M.1    Rodgers, A.2    Bennett, D.A.3    Parag, V.4    Suh, I.5    Ueshima, H.6    MacMahon, S.7
  • 13
    • 0032513878 scopus 로고    scopus 로고
    • the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S, the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351(9118):1755-1762.
    • (1998) Lancet , vol.351 , Issue.9118 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6    Menard, J.7    Rahn, K.H.8    Wedel, H.9    Westerling, S.10
  • 14
    • 0032511601 scopus 로고    scopus 로고
    • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317(7160):713-720.
    • (1998) BMJ , vol.317 , Issue.7160 , pp. 713-720
  • 15
    • 0035992083 scopus 로고    scopus 로고
    • on behalf of the HOMED-BP study group. Rational and design of HOMED-BP study: Hypertension objective treatment based on measurement by electrical devices of blood pressure study
    • Fujiwara T, Nishimura T, Ohkuko T, Imai Y, on behalf of the HOMED-BP study group. Rational and design of HOMED-BP study: hypertension objective treatment based on measurement by electrical devices of blood pressure study. Blood Pressure Monit 2002;7(1):77-82.
    • (2002) Blood Pressure Monit , vol.7 , Issue.1 , pp. 77-82
    • Fujiwara, T.1    Nishimura, T.2    Ohkuko, T.3    Imai, Y.4
  • 17
    • 19944431172 scopus 로고    scopus 로고
    • The second progress report on the HOMED-BP study: Hypertension objective treatment based on measurement by electrical devices of blood pressure study
    • Saito S, Asayama K, Ohkubo T, Kikuya M, Metoki H, Hashimoto J, Totsune K, Yukio M, Imai Y. The second progress report on the HOMED-BP study: hypertension objective treatment based on measurement by electrical devices of blood pressure study. Blood Press Monit 2004;9(5):243-247.
    • (2004) Blood Press Monit , vol.9 , Issue.5 , pp. 243-247
    • Saito, S.1    Asayama, K.2    Ohkubo, T.3    Kikuya, M.4    Metoki, H.5    Hashimoto, J.6    Totsune, K.7    Yukio, M.8    Imai, Y.9
  • 19
    • 0034959116 scopus 로고    scopus 로고
    • Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults
    • White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit 2001;6(2):107-110.
    • (2001) Blood Press Monit , vol.6 , Issue.2 , pp. 107-110
    • White, W.B.1    Anwar, Y.A.2
  • 20
    • 2642514734 scopus 로고    scopus 로고
    • the Ohasama Study. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study
    • Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y, the Ohasama Study. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens 2004;22(6):1099-1104.
    • (2004) J Hypertens , vol.22 , Issue.6 , pp. 1099-1104
    • Ohkubo, T.1    Asayama, K.2    Kikuya, M.3    Metoki, H.4    Hoshi, H.5    Hashimoto, J.6    Totsune, K.7    Satoh, H.8    Imai, Y.9
  • 21
    • 1542401212 scopus 로고    scopus 로고
    • Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients
    • Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291(11):1342-1349.
    • (2004) JAMA , vol.291 , Issue.11 , pp. 1342-1349
    • Bobrie, G.1    Chatellier, G.2    Genes, N.3    Clerson, P.4    Vaur, L.5    Vaisse, B.6    Menard, J.7    Mallion, J.M.8
  • 22
    • 1442359550 scopus 로고    scopus 로고
    • O'Brien ET, the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: A randomized controlled trial. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial
    • Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, O'Brien ET, the Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA 2004;291(8):955-964.
    • (2004) JAMA , vol.291 , Issue.8 , pp. 955-964
    • Staessen, J.A.1    Den Hond, E.2    Celis, H.3    Fagard, R.4    Keary, L.5    Vandenhoven, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.